RELIANCE: Return to Work and Living Healthy After Head and Neck Cancer

Sponsor
University of Leipzig (Other)
Overall Status
Terminated
CT.gov ID
NCT03065634
Collaborator
Universitätsklinikum Leipzig (Other), Jena University Hospital (Other), Klinikum St. Georg gGmbH (Other), Stadtisches Klinikum Dresden (Other), German Cancer Aid (Other)
39
1
2
24
1.6

Study Details

Study Description

Brief Summary

Based on a randomized controlled trial, the manualized group intervention Return to work and living healthy after head and neck cancer (RELIANCE) for head and neck cancer survivors will be tested against a non-manualized control intervention (social counseling) in order to evaluate the efficacy of the RELIANCE intervention compared to the control condition. The study design includes two phases, the initial study phase (pilot study) and the intervention study (RCT). The aim of the pilot study is to implement and ensure the necessary standardized procedures for the implementation of patient recruitment and interventions. In the randomized controlled trial, potential participants are assigned to the intervention group or to the control group.

Condition or Disease Intervention/Treatment Phase
  • Behavioral: Return to work and living healthy after head and neck cancer
  • Behavioral: socio-legal counseling
N/A

Study Design

Study Type:
Interventional
Actual Enrollment :
39 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Masking Description:
Open Label
Primary Purpose:
Treatment
Official Title:
Return to Work and Living Healthy After Head and Neck Cancer
Actual Study Start Date :
Jan 1, 2017
Actual Primary Completion Date :
Sep 30, 2018
Actual Study Completion Date :
Dec 31, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Manualized RELIANCE intervention

Return to work and living healthy after head and neck cancer (RELIANCE) is a 2-months group intervention for head and neck cancer patients delivered by a trained psychotherapist and a peer in eight sessions.

Behavioral: Return to work and living healthy after head and neck cancer
Return to work and living healthy after head and neck cancer (RELIANCE) is a 2-months group intervention for head and neck cancer patients delivered by a trained psychotherapist and a peer in eight sessions. The individual sessions aim to improve work ability, quality of life and psychological well-being

Active Comparator: Non-manualized socio-legal counseling

two socio-legal counseling sessions delivered by a social worker

Behavioral: socio-legal counseling
Non-manualized socio-legal counseling two socio-legal counseling sessions delivered by a social worker

Outcome Measures

Primary Outcome Measures

  1. Work ability [directly after intervention and at six months follow-up]

    Work-Ability-Index, short version (WAI)

  2. Pattern of work-related coping behaviour [directly after intervention and at six months follow-up]

    Pattern of work-related coping behaviour, short Version (AVEM-44)

Secondary Outcome Measures

  1. Cancer-specific health-related quality of Life (global, functioning, symptom burden) [directly after intervention and at six months follow-up]

    Quality of Life Core Questionnaire of the European Organisation for Research and Treatment of Cancer (EORTC-QLQ-C30)

  2. Quality of life and symptoms specific to head and neck cancer [directly after intervention and at six months follow-up]

    Head and Neck Module of the European Organisation for Research and Treatment of Cancer (EORTC-H&N35)

  3. anxiety, depression and psychological distress in patients with somatic diseases [directly after intervention and at six months follow-up]

    Hospital Anxiety and Depression Scale (HADS)

  4. health behavior and health related attitudes and knowledge about specific diseases [directly after intervention and at six months follow-up]

    questionnaire measuring health behavior and health related attitudes and knowledge about specific diseases (FEG)

  5. general self-efficacy expectation [directly after intervention and at six months follow-up]

    general self-efficacy expectation (ASKU)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Diagnosis of laryngea, hypopharyngeal, oropharyngeal, tonsil or base of the tongue cancer within the last six months

  • Curative treatment

  • Completion of primary and follow-up Treatment

  • Fluency in German

  • Written informed and voluntary consent

  • Psychological distress (Distress Thermometer score > 4)

  • Self-perceived prognosis of employment (SPE score ≥ 1)

Exclusion Criteria:
  • Alcohol dependency with physical withdrawal symptoms (CAGE score ≥ 3 and current use of alcohol)

  • Acute suicidal tendencies

  • Receiving old-age pension or will receive old-age pension within the next 12 months

  • Cognitive impairment indicated in the medical records or by the attending doctor

  • Being in psychotherapy

Contacts and Locations

Locations

Site City State Country Postal Code
1 University Medical Center Leipzig Leipzig Saxony Germany 04103

Sponsors and Collaborators

  • University of Leipzig
  • Universitätsklinikum Leipzig
  • Jena University Hospital
  • Klinikum St. Georg gGmbH
  • Stadtisches Klinikum Dresden
  • German Cancer Aid

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Additional Information:

Publications

None provided.
Responsible Party:
Anja Mehnert, Prof. Dr., University of Leipzig
ClinicalTrials.gov Identifier:
NCT03065634
Other Study ID Numbers:
  • 93000-133
First Posted:
Feb 28, 2017
Last Update Posted:
Nov 5, 2020
Last Verified:
Nov 1, 2020
Individual Participant Data (IPD) Sharing Statement:
Undecided
Plan to Share IPD:
Undecided
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 5, 2020